> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Awards 12 Grants for Rare Disease Studies
- URL: https://www.fdaweb.com/fda-awards-12-grants-for-rare-disease-studies/
- Published: 2018-09-24T12:00:00.000Z
- Updated: 2026-09-15T00:33:43.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5142425

FDA has awarded 12 new clinical trial research grants totaling more than $18 million over the next four years to help develop medical products for patients with rare diseases. The funding helps support early-stage development activities targeting rare diseases that don’t have effective treatments. “By providing seed capital, these FDA-administered grants enable researchers to prove out important concepts,” an [agency release](https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm621490.htm?ref=fdaweb.com) says. For example, Alkeus Pharmaceuticals received $1.75 million for a Phase 2 study of ALK-001 for treating Stargardt disease, and Arizona State University received $2 million for a Phase 2 study of oral vancomycin for treating primary sclerosing cholangitis. For a full listing of the grants, click on the news release link above.